TABLE 3.

Time-to-onset analysis for signals with Subcutaneous and Oral prioritization.

Prioritization				Weibull distribution				Failure type
	Case	TTO (days)		Scale parameter		Shape parameter
	n	Median (IQR)	Min–max	α	95% CI	β	95% CI
Subcutaneous	1793	22 (6–67)	1–1789	46.4	42.50–50.30	0.58	0.56–0.60	Early failure
Oral	318	15 (4–54.25)	1–1,006	33.36	27.08–39.63	0.61	0.57–0.67	Early failure

Note: n, number of cases with available time-to-onset; IQR, interquartile range; TTO, Time-to-onset.